Spatial statistical analysis of Coronavirus Disease 2019 (Covid-19) in China

被引:30
|
作者
Li, Huling [1 ]
Li, Hui [2 ]
Ding, Zhongxing [3 ]
Hu, Zhibin [3 ]
Chen, Feng [3 ]
Wang, Kai [4 ]
Peng, Zhihang [3 ]
Shen, Hongbing [3 ]
机构
[1] Xinjiang Med Univ, Coll Publ Hlth, Urumqi, Peoples R China
[2] Xinjiang Med Univ, Cent Lab, Urumqi, Peoples R China
[3] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China
[4] Dept Med Engn & Technol, Urumqi, Xinjiang, Peoples R China
关键词
Coronavirus disease 2019 (Covid-l9); Hubei province area; Spatial statistics; Clusters; China; HEAVY-METALS; AUTOCORRELATION;
D O I
10.4081/gh.2020.867
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The cluster of pneumonia cases linked to coronavirus disease 2019 (Covid-19), first reported in China in late December 2019 raised global concern, particularly as the cumulative number of cases reported between 10 January and 5 March 2020 reached 80,711. In order to better understand the spread of this new virus, we characterized the spatial patterns of Covid-19 cumulative cases using ArcGIS v.10.4.1 based on spatial autocorrelation and cluster analysis using Global Moran's I (Moran. 1950), Local Moran's I and Getis-Ord General G (Ord and Getis, 2001). Up to 5 March 2020, Hubei Province, the origin of the Covid-19 epidemic, had reported 67,592 Covid-19 cases, while the confirmed cases in the surrounding provinces Guangdong, Henan, Zhejiang and Hunan were 1351, 1272, 1215 and 1018, respectively. The top five regions with respect to incidence were the following provinces: Hubei (11.423/10,000), Zhejiang (0.212/10,000), Jiangxi (0.201/10,000), Beijing (0.196/10,000) and Chongqing (0.186/10,000). Global Moran's I analysis results showed that the incidence of Covid-19 is not negatively correlated in space (p=0.407413>0.05) and the High-Low cluster analysis demonstrated that there were no high-value incidence clusters (p=0.076098>0.05), while Local Moran's I analysis indicated that Hubei is the only province with High-Low aggregation (p<0.0001).
引用
收藏
页码:11 / 18
页数:8
相关论文
共 50 条
  • [1] Drug treatment of coronavirus disease 2019 (COVID-19) in China
    Jin, Zhe
    Liu, Jing-Yi
    Feng, Rang
    Ji, Lu
    Jin, Zi-Li
    Li, Hai-Bo
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 883
  • [2] Coronavirus Disease 2019 (COVID-19) A Perspective from China
    Zu, Zi Yue
    Jiang, Meng Di
    Xu, Peng Peng
    Chen, Wen
    Ni, Qian Qian
    Lu, Guang Ming
    Zhang, Long Jiang
    RADIOLOGY, 2020, 296 (02) : E15 - E25
  • [3] Coronavirus Disease 2019 (COVID-19)
    Ebell, Mark H.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (10) : 581 - 581
  • [4] Coronavirus Disease 2019 (COVID-19)
    不详
    JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2020, 65 (06) : 833 - 834
  • [5] Coronavirus Disease 2019 (COVID-19)
    Goldust, Mohamad
    BIOLOGY-BASEL, 2022, 11 (08):
  • [6] The Coronavirus Disease 2019 (COVID-19)
    Hageman, Joseph R.
    PEDIATRIC ANNALS, 2020, 49 (03): : E99 - E100
  • [7] Coronavirus Disease 2019 (COVID-19)
    Barry, Henry C.
    AMERICAN FAMILY PHYSICIAN, 2020, 102 (09) : 518 - 518
  • [8] Impfung gegen coronavirus disease 2019 (COVID-19)Vaccination against coronavirus disease 2019 (COVID-19)
    Birgit Weinberger
    Zeitschrift für Gerontologie und Geriatrie, 2022, 55 : 558 - 563
  • [9] Coronavirus disease 2019 (COVID-19) and spatial control in times of pandemic
    Carneiro, Marcelo
    Darsie, Camilo
    Koepp, Janine
    Valim, Andreia Rosane de Moura
    Possuelo, Lia Goncalves
    Kist, Marina Weiss
    Krummenauer, Eliane Carlosso
    de Menezes, Rochele Mosman
    Vargas, Lea
    Brenner, Pola A.
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (03): : 404 - 405
  • [10] COVID-19 (Coronavirus Disease 2019): A New Coronavirus Disease
    Dousari, Amin Sadeghi
    Moghadam, Majid Taati
    Satarzadeh, Naghmeh
    INFECTION AND DRUG RESISTANCE, 2020, 13 : 2819 - 2828